The DOI matches its Crossref record; its reference list is not available; 94 of the 196 sources its claims cite were checked for support.
Dietary sugar consumption and health: umbrella review
Open accessAbstract
Objective: To evaluate the quality of evidence, potential biases, and validity of all available studies on dietary sugar consumption and health outcomes. Design: Umbrella review of existing meta-analyses. Data sources: PubMed, Embase, Web of Science, Cochrane Database of Systematic Reviews, and hand searching of reference lists. Inclusion criteria: Systematic reviews and meta-analyses of randomised controlled trials, cohort studies, case-control studies, or cross sectional studies that evaluated the effect of dietary sugar consumption on any health outcomes in humans free from acute or chronic diseases. Results: The search identified 73 meta-analyses and 83 health outcomes from 8601 unique articles, including 74 unique outcomes in meta-analyses of observational studies and nine unique outcomes in meta-analyses of randomised controlled trials. Significant harmful associations between dietary sugar consumption and 18 endocrine/metabolic outcomes, 10 cardiovascular outcomes, seven cancer outcomes, and 10 other outcomes (neuropsychiatric, dental, hepatic, osteal, and allergic) were detected. Moderate quality evidence suggested that the highest versus lowest dietary sugar consumption was associated with increased body weight (sugar sweetened beverages) (class IV evidence) and ectopic fatty accumulation (added sugars) (class IV evidence). Low quality evidence indicated that each serving/week increment of sugar sweetened beverage consumption was associated with a 4% higher risk of gout (class III evidence) and each 250 mL/day increment of sugar sweetened beverage consumption was associated with a 17% and 4% higher risk of coronary heart disease (class II evidence) and all cause mortality (class III evidence), respectively. In addition, low quality evidence suggested that every 25 g/day increment of fructose consumption was associated with a 22% higher risk of pancreatic cancer (class III evidence). Conclusions: High dietary sugar consumption is generally more harmful than beneficial for health, especially in cardiometabolic disease. Reducing the consumption of free sugars or added sugars to below 25 g/day (approximately 6 teaspoons/day) and limiting the consumption of sugar sweetened beverages to less than one serving/week (approximately 200-355 mL/week) are recommended to reduce the adverse effect of sugars on health. Systematic review registration: PROSPERO CRD42022300982.
Overview
CoChat Summary
TL;DR
This umbrella review of 73 meta-analyses found that high dietary sugar consumption was generally more harmful than beneficial across 83 health outcomes, especially cardiometabolic disease. Most evidence was low or very low quality, with no high-quality or class I evidence identified.
Key findings
- From 8601 unique articles, the review included 73 meta-analyses and 83 health outcomes: 74 outcomes from observational-study meta-analyses and 9 from randomised controlled trial meta-analyses. Significant harmful associations were found for 18 endocrine/metabolic, 10 cardiovascular, 7 cancer, and 10 other outcomes.
- Moderate-quality evidence linked highest versus lowest sugar sweetened beverage consumption to increased body weight (weighted mean difference 0.85, 95% CI 0.50 to 1.20) and added sugar consumption to ectopic fat accumulation (liver fat standardised mean difference 0.93, 95% CI 0.64 to 1.21; muscle fat 0.63, 95% CI 0.23 to 1.04).
- Low-quality evidence indicated each serving/week increment of sugar sweetened beverages was associated with 4% higher gout risk (RR 1.04, 95% CI 1.02 to 1.07); each 250 mL/day increment was associated with 17% higher coronary heart disease risk (RR 1.17, 95% CI 1.11 to 1.23) and 4% higher all-cause mortality (HR 1.04, 95% CI 1.02 to 1.06); each 25 g/day increment of fructose was associated with 22% higher pancreatic cancer risk (RR 1.22, 95% CI 1.08 to 1.37).
- The authors recommend reducing free or added sugars to below 25 g/day (about 6 teaspoons/day) and limiting sugar sweetened beverages to less than one serving/week (about 200-355 mL/week). No high-quality or class I evidence was found; most outcomes were low or very low quality and class III, IV, or non-significant.
Methods
- Design: umbrella review of existing systematic reviews and meta-analyses, prospectively registered in PROSPERO (CRD42022300982).
- Data sources: PubMed, Embase, Web of Science, and Cochrane Database of Systematic Reviews from inception through January 2022, plus hand searching of reference lists.
- Inclusion: systematic reviews and meta-analyses of randomised controlled trials, cohort, case-control, or cross-sectional studies evaluating dietary sugar consumption and any health outcome in humans free from acute or chronic diseases. Two reviewers independently screened, extracted data, and assessed quality using AMSTAR, GRADE, and evidence classification criteria; effects were reanalysed with random or fixed effects models, heterogeneity, and publication bias tests where possible.
Limitations
- The paper states that original studies used different dietary assessment methods (food records, 24-hour recall, food frequency questionnaires, dietary history), causing unavoidable measurement bias; most studies focused on beverages pre-sweetened before purchase; and the review could not evaluate sugars in some foods such as chocolate and ice cream because sugar consumption data could not be extracted.
- The paper states that sugar sweetened beverage types and dosages varied, exposure units differed across studies, and dose-response or stratification analyses by beverage type were unavailable for most outcomes; other compounds in sugar sweetened beverages (e.g., 4-methylimidazole, pesticides, artificial sweeteners, sodium benzoate, sulfites) may confound effects. It also states that original studies’ competing interests were not investigated, and only two included meta-analyses were funded by sugar sweetened beverage companies, one of which was selected for data extraction.
- Evident in the text: the review depends on the quality of included meta-analyses; all observational evidence was graded low or very low, no high-quality or class I evidence was found, about 46% of reanalysed outcomes had significant heterogeneity, and publication bias was detected for some outcomes including type 2 diabetes mellitus (sugar sweetened beverages), overall cancer risk, and hypertension in adults (sugar sweetened beverages).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
76 Valid · 2 Not valid · 68 Not checked · 65 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Another dose-response meta-analysis showed that a one serving/week increment in artificially sweetened beverages was associated with a 4% higher risk of gout (risk ratio 1.04, 95% confidence interval 1.02 to 1.07) (low; III).”
§ Dietary sugar consumption and health: umbrella review > Results > Endocrine and metabolic outcomes
What the sources say
- Disputedcites [13] sourceExperimental — accuracy not yet measured
Our copy reports the exact estimate the claim gives — RR=1.04, 95% CI 1.02 to 1.07 per serving/week for incident gout — but in the Dose–response analysis (Additional analysis) it assigns it to sugar-sweetened beverage (SSB) intake, not artificially sweetened beverages; the GRADE table note likewise credits the significant linear dose–response (p=0.0001) to SSB intake, and the Study selection/Abstract scope is food sources of fructose-containing sugars (SSBs, fruit juice, fruit), with no ASB analysis anywhere. The certainty qualifier also conflicts: the GRADE assessment (Additional analysis) rates the SSB association as moderate (downgrade one for indirectness, upgrade two for large magnitude and dose–response), i.e. II, not 'low; III'. So the numbers appear lifted from this paper but relabelled to a different exposure. (LLM, conf=0.75)
Checked by a reasoning model — may be wrong.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Furthermore, comparison of higher sugar sweetened beverage consumption with non-sugar sweetened beverage consumption indicated a 55% (odds ratio 1.55, 95% confidence interval 1.32 to 1.82) increased risk of obesity in children associated with higher consumption (low; II).”
§ Dietary sugar consumption and health: umbrella review > Results > Endocrine and metabolic outcomes
What the sources say
- Partly supportedcites [3] sourceExperimental — accuracy not yet measured
The Results section 'Effects of increasing dietary sugars on measures of body fatness in children' reports exactly this pooled estimate from five cohort studies (seven comparisons) in children: OR 1.55 (95% CI 1.32 to 1.82), so the magnitude, direction, population and uncertainty match. However, the source describes the contrast as children consuming about one daily serving of sugar sweetened beverages versus children consuming none or very little SSB, and the outcome as the odds of being overweight (Discussion likewise: 'a link between intake of sugar sweetened beverages and the risk of becoming overweight') — not a comparison against non-sugar sweetened beverage intake, and not obesity specifically. The '(low; II)' quality rating is the citing document's own grading and is not stated in the source. (LLM, conf=0.78)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Moderate quality evidence suggested that the highest versus lowest dietary sugar consumption was associated with increased body weight (sugar sweetened beverages) (class IV evidence)”
- Also stated in: § Endocrine and metabolic outcomes · plain
“A meta-analysis of six randomised controlled trials found that sugar sweetened beverage consumption was significantly associated with increased body weight for highest versus lowest consumption (weighted mean difference 0.85, 95% confidence interval 0.50 to 1.20) (moderate; IV (the quality of evidence is expressed as “GRADE, evidence class”)).”
§ Dietary sugar consumption and health: umbrella review > Abstract > Results
What the sources say
- Partly supportedcites [53] sourceExperimental — accuracy not yet measured
Our copy of Malik et al. (2013) clearly supports the directional content: the Prospective cohort studies section reports 'a positive association between SSB consumption and BMI' (0.07 kg/m2 per additional 12-oz serving/d in children, n=25,745) and the SSBs and body weight in adults section reports 0.22 kg extra 1-y weight gain per serving/d (n=170,141), with trials in adults showing WMD 0.85 kg. However, the paper pools per-serving (continuous) increments, not a 'highest versus lowest' contrast — Data synthesis and analysis states that studies reporting categorical estimates (18,19; Palmer 25) were converted to continuous variables by assigning medians to intake categories. The 'moderate quality / class IV evidence' grading is likewise not the paper's: its Risk of bias section rates individual cohorts on the Newcastle-Ottawa scale ('good quality' if score >=7) and RCTs with the Cochrane tool, with no GRADE-style body-of-evidence rating. Those two qualifiers attributed to this source are unsupported. (LLM, conf=0.78)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Endocrine and metabolic outcomes · plain
Every source the paper cites for this claim was checked and supports it.
In the paper
“The authors conducted a dose-response analysis and showed that body mass index in children increased by 0.07 units for every one serving/day increment of sugar sweetened beverages (weighted mean difference 0.07, 0.01 to 0.12) (low; IV).”
§ Dietary sugar consumption and health: umbrella review > Results > Endocrine and metabolic outcomes
What the sources say
- Supportedcites [53] source
The Prospective cohort studies section reports a pooled BMI increase of 0.07 (95% CI: 0.01, 0.12) per additional daily 12-oz serving of sugar-sweetened beverages among children and adolescents, matching the cited estimate. The estimate is an association measured over the time period specified in each study. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“each 250 mL/day increment of sugar sweetened beverage consumption was associated with a 17% and 4% higher risk of coronary heart disease (class II evidence) and all cause mortality (class III evidence), respectively.”
- Also stated in: § Cardiovascular outcomes · plain
“Dose-response analysis showed that each 250 mL/day increment of sugar sweetened beverage consumption was positively associated with a 17% (risk ratio 1.17, 1.11 to 1.23) higher risk of coronary heart disease (low; II).”
§ Dietary sugar consumption and health: umbrella review > Abstract > Results
What the sources say
- Partly supportedcites [10] sourceExperimental — accuracy not yet measured
The Sugar-sweetened beverages section (p. 11) states exactly the attributed effect: each additional 250 ml/day of SSB was associated with CHD RR 1.17 (95% CI 1.11–1.23, n = 4), i.e. a 17% higher risk. However, the quality qualifier does not match: the Quality of meta-evidence section (p. 11) reports that NutriGrade grading for CHD was 'low' only for refined grains and eggs and 'moderate' for the other ten food groups, which includes SSB, and the paper uses no 'class I/II/III' terminology at all (its levels are high, moderate, low, very low; p. 4). So the '17% per 250 mL/day for CHD' is supported while '(low quality, class II evidence)' is not — the source rates that association with moderate confidence. (LLM, conf=0.78)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Cardiovascular outcomes · plain
138 more claims · 64 with their cited sources checked
Create a free account to see all 211 claims and to verify the 102 references still open.
- It may state two separate claims as one. 47
- Probably not a substantial claim. 26
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It is clear that reducing intake of added sugars in the diet, including those provided through SSBs, is an important step to improving overall diet quality and cardiometabolic risk factors (12,13).”
From Prebiotic soda lowers postprandial glucose compared to traditional soda pop: a randomized controlled trial (2025) · cites this paper as [13]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This limitation may partially account for differences in the strength of evidence observed in our review compared with another recent umbrella review focusing on dietary sugar consumption”
From Ultra-processed food exposure and adverse health outcomes: umbrella review of epidemiological meta-analyses (2024) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“That review found no convincing (class I) evidence for adverse health outcomes linked to dietary sugar or sugar sweetened beverage consumption.”
From Ultra-processed food exposure and adverse health outcomes: umbrella review of epidemiological meta-analyses (2024) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Dietary sugar consumption and health: umbrella review > Abstract > Results
“each serving/week increment of sugar sweetened beverage consumption was associated with a 4% higher risk of gout”
§ Dietary sugar consumption and health: umbrella review > Results > Endocrine and metabolic outcomes
“a one serving/week increment in artificially sweetened beverages was associated with a 4% higher risk of gout (risk ratio 1.04, 95% confidence interval 1.02 to 1.07)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Dietary sugar consumption and health: umbrella review > Discussion > Principal findings and possible explanations
“dietary sugar consumption has also been shown to be negatively associated with some neuropsychiatric diseases, such as depression and attention deficit/hyperactivity disorder.”
§ Dietary sugar consumption and health: umbrella review > Results > Other outcomes
“a harmful association between sugar sweetened beverage consumption and the risk of depression was observed in a meta-analysis of 10 observational studies (risk ratio 1.31, 1.24 to 1.39)”
Citations
No citation lists for this paper
No citation lists for this paper yet — checked again daily.
References 153 · Cited by 348
Metadata
- Authors
- Huang, Y., Chen, Z., Chen, B., Li, J., Yuan, X., Li, J., Wang, W., Dai, T., Chen, H., Wang, Y., Wang, R., Wang, P., Guo, J., Dong, Q., Liu, C., Wei, Q., Cao, D., & Liu, L.
- Affiliations
- Sichuan University (CN)
- University of California Davis Medical Center (US)
- Corresponding author
- Liu, Liangren
- ORCID
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2023-04-05
- Volume
- 381
- Pages
- e071609
- ISSN
- 1756-1833 (ISSN-L)
- PMC
- PMC10074550
- OpenAlex
- W4362636766
- Cited by
- 348
- References
- 153
- Citations by year
- 2026: 106 · 2025: 117 · 2024: 104 · 2023: 21
- FWCI
- 70.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BMJ (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China
- Department of Science and Technology of Sichuan Province
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Health Sciences › Nursing › Nutrition and Dietetics › Biochemical Analysis and Sensing Techniques
- Keywords
- sugar consumption, free sugars, added sugars, sugar-sweetened beverages, fructose, body weight, ectopic fat deposition, gout, coronary artery disease, all-cause mortality, pancreatic cancer, cardiometabolic disease, cancer risk, dental health, neuropsychiatric outcomes
- MeSH terms
- Dietary Sugars, Sugars, Systematic Reviews as Topic, Beverages, Cross-Sectional Studies, Humans, Meta-Analysis as Topic, Weight Gain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dietary sugar consumption and health: umbrella review. https://app.cochat.ai/papers/10.1136/bmj-2022-071609
- The paper
- Huang, Y., Chen, Z., Chen, B., Li, J., Yuan, X., Li, J., Wang, W., Dai, T., Chen, H., Wang, Y., Wang, R., Wang, P., Guo, J., Dong, Q., Liu, C., Wei, Q., Cao, D., & Liu, L. (2023). Dietary sugar consumption and health: umbrella review. BMJ. https://doi.org/10.1136/bmj-2022-071609
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.